Company Quick10K Filing
Kaya Holdings
10-K 2019-12-31 Filed 2020-05-13
10-Q 2019-09-30 Filed 2019-11-19
10-Q 2019-06-30 Filed 2019-08-19
10-Q 2019-03-31 Filed 2019-05-21
10-K 2018-12-31 Filed 2019-04-19
10-Q 2018-09-30 Filed 2018-11-19
10-Q 2018-06-30 Filed 2018-08-20
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-04-17
10-Q 2017-09-30 Filed 2017-11-20
10-Q 2017-06-30 Filed 2017-08-21
10-Q 2017-03-31 Filed 2017-05-22
10-K 2016-12-31 Filed 2017-04-17
10-Q 2016-09-30 Filed 2016-11-21
10-Q 2016-06-30 Filed 2016-08-22
10-Q 2016-03-31 Filed 2016-05-23
10-K 2015-12-31 Filed 2016-05-16
10-Q 2015-09-30 Filed 2015-11-24
10-Q 2015-06-30 Filed 2015-08-19
10-Q 2015-03-31 Filed 2015-05-20
10-K 2014-12-31 Filed 2015-04-15
10-Q 2014-09-30 Filed 2014-11-19
10-Q 2014-06-30 Filed 2014-08-19
10-Q 2014-03-31 Filed 2014-05-28
10-K 2013-12-31 Filed 2014-04-15
10-Q 2013-09-30 Filed 2013-11-18
10-Q 2013-06-30 Filed 2013-08-15
10-Q 2013-03-31 Filed 2013-06-25
10-K 2012-12-31 Filed 2013-04-24
10-Q 2012-09-30 Filed 2013-01-22
10-Q 2012-06-30 Filed 2012-08-20
10-Q 2012-03-31 Filed 2012-05-23
8-K 2020-05-13
8-K 2020-03-30
8-K 2019-11-20
8-K 2019-11-04
8-K 2019-07-30
8-K 2018-12-11
8-K 2018-10-23
8-K 2018-06-14

Kaya Holdings Financials

KAYS Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Peerstream (PEER) 27,093 80% -1,005.5 -2% 19,727 3,788 12,704 10,180 -484 -23 23,468
Social Life Network (WDLF) 27,065 -4% -7.4 367,804,900% 814 177 -8 -3,678 -3,677 27,048
Know Labs (KNWN) 26,998 22% -9.9 -272% 2,640 5,937 2,303 514 -7,187 -3,196 31,595
Cannabis Sativa (CBDS) 26,935 57% -15.1 -50% 4,419 2,819 813 467 -2,228 -1,770 26,713
Innovation Pharmaceuticals (IPIX) 26,737 -3.3 -190% 4,315 8,859 0 0 -8,181 -7,945 25,827
Quaint Oak Bancorp (QNTO) 26,452 3.1 1% 293,820 268,272 0 0 1,880 6,849 20,946
Cadus (KDUS) 26,288 -55.5 -1% 38,250 654 0 0 -434 -432 23,980
Crexendo (EXE) 26,258 0% 23.5 12% 7,386 3,735 13,805 0 903 974 22,854
Uniroyal Global (UNIR) 26,159 17% 6.7 2% 67,073 55,045 71,523 12,088 1,274 4,550 30,305
OvaScience (OVAS) 26,153 -46% 0.7 -59% 49,234 4,323 294 -134 -29,280 -28,277 -20,247
Kaya Holdings (KAYS) 25,921 53% 2.7 334% 2,709 17,268 722 384 9,036 9,641 25,920
Micropac Industries (MPAC) 25,912 83% 6.5 8% 29,372 2,587 32,485 27,042 2,245 2,055 13,455
Relmada Therapeutics (RLMD) 25,838 -1.0 -207% 8,514 2,537 0 0 -17,607 -17,607 17,988
International Isotopes (INIS) 25,776 53% -390.3 -4% 14,865 14,967 7,001 3,717 -658 -63 24,652
Madison Bank (MBCQ) 25,652 8.8 1% 148,174 114,817 0 0 960 2,003 17,694
PwrCor (PWCO) 25,241 0% -63.4 -91% 452 591 0 -413 -397 25,189
Spindletop Oil & Gas (SPND) 25,196 0% 57.3 0% 24,594 7,751 5,783 0 0 196 11,229
RegeneRx (RGRX) 24,986 0% -25.3 -109% 971 3,011 58 0 -1,055 -952 24,104
Pharma-Bio Serv (PBSV) 24,957 32% 4.9 6% 26,251 4,460 14,683 4,638 1,610 2,065 10,162
Exactus (EXDI) 24,815 -0% -6.3 -40% 11,449 4,055 216 -0 -4,625 -3,970 24,909

Balance Sheet ($'000)2012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash99081001123045419830312415294413071,2551,05628631825617931611211412011
Accounts Receivable
Inventory1844453010551444084165152151118137146137132119124122
PP&E158755438646181851542132122141941933053748938989159692,3782,6852,7052,7052,705
Assets18417716717316716431421261511822735374804444073697101,7721,6731,9381,4421,4141,3482,8912,6443,1363,0672,709
Accounts Payable
Long-Term Debt527977978551,21246025567744140014595,8846,0389999
Liabilities1,4722,0571,0911,1481,2501,3111,3171,2569539921,4241,0651,7675,4124,5944,8265,15421,70021,45315,43519,00530,56721,04922,49618,21025,94922,25718,36817,268
Stockholders' Equity-1,288-1,881-925-975-1,083-1,146-1,314-1,114-827-841-1,241-792-1,230-4,931-4,150-4,419-4,785-20,990-19,681-13,762-17,067-29,125-19,634-21,149-15,319-23,305-19,121-15,302-14,559
Income Statement ($'000)2012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue0037302733233245246263199145200321299255291304264249209
Cost of Revenue00000000023852212616513012613270801231221031181371469399
Gross Profit00000000014222311108801161376675120198177153173167118156109
R&D
SG&A2632213010277611411,118117108109167344434368402164175261243217234
Tax0000000000000000000000
Net Income-249-275346-5044381-667-50-448-163-784-1,388368-1,328570401-1,069-19,305-3,0885,889-514-16,33012,748-1,4615804,2503,802985
Cash Flow ($'000)2012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-140-19-55-43-15-11-115-141-327-197-137-277-132-222-143-212-512-719-606-380-509-445-149-465-213-199-234
Cash Investing040-100-6-57-2-8-5-44-1330-280-27-540-70-37-78-48-2000
Cash Financing124662381411232115345210200525862501141595891,718495150612419150650235205125